相关实验视频
Updated: Jan 30, 2026

12:03
Fertility Preservation in Patients with Severe Ovarian Dysfunction
Published on: March 25, 2021
5.0K
在患有严重支气管炎的儿科患者中,免疫失调的标志物
Katherine Hickey1, Conor Gruber2, Sofija Buta-Panov3
1Department of Pediatric Critical Care, Mount Sinai Kravis Children's Hospital, New York, NY, USA.
概括
患有支气管炎的住院儿童表现出明显的免疫细胞差异,特别是在血细胞状树突细胞和埃索诺菲尔细胞. 与健康对照人群相比,这些患者的呼吸道炎症标志物也发生了显著的变化.
科学领域:
- 儿科免疫学 儿科免疫学
- 呼吸系统药物 呼吸系统药物
- 细胞免疫学 细胞免疫学
背景情况:
- 支气管炎是一种常见的儿科呼吸系统疾病.
- 患有支气管炎的儿童的免疫表型尚未完全理解.
- 了解支气管炎的免疫反应对于开发向疗法至关重要.
研究的目的:
- 为了研究患有支气管炎的住院儿童的独特免疫类型.
- 为了比较住院患者和健康对照者之间的免疫细胞群和细胞因子概况.
- 确定与儿科支气管炎的呼吸道炎症相关的关键免疫因素.
主要方法:
- 使用流细胞计,对免疫细胞群的比较分析 (例如,等离子体细胞状树突细胞,埃索诺菲尔).
- 在患者样本中量化细胞因子水平.
- 统计分析以确定住院儿童和对照儿童之间的显著差异.
主要成果:
- 与对照人群相比,在患有支气管炎的住院儿童中,观察到血细胞状树突细胞和埃索诺菲尔细胞的频率存在显著差异.
- 在住院患者中发现了参与呼吸道炎症的特定细胞因子的水平升高.
- 这项研究强调了与严重支气管炎相关的独特免疫特征.
结论:
- 患有支气管炎的儿童呈现出一种独特的免疫表型,其特征是发生变化的树突细胞和生细胞群.
- 与呼吸道炎症相关的特定细胞因子在住院儿科患者中显著不同.
- 这些发现有助于了解支气管炎的免疫基础,并可能为未来的治疗策略提供信息.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
259
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution
301
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
301
Pharmacokinetics in Pediatric Patients: Drug Metabolism
223
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
291
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
291
What is the Immune System?
127.7K
Overview
127.7K
Humoral Immune Responses
83.8K
Overview
83.8K

